195 related articles for article (PubMed ID: 19811329)
21. Autoimmune cytopenia in chronic lymphocytic leukemia: diagnosis and treatment.
Yevstakhevych YL; Vyhovska YI; Yevstakhevych IY; Vyhovska OY; Pelenyo NV; Semerak MM; Novak VL; Loginsky VE
Exp Oncol; 2020 Dec; 42(4):318-323. PubMed ID: 33355861
[TBL] [Abstract][Full Text] [Related]
22. Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisone.
Bowen DA; Call TG; Shanafelt TD; Kay NE; Schwager SM; Reinalda MS; Rabe KG; Slager SL; Zent CS
Leuk Lymphoma; 2010 Apr; 51(4):620-7. PubMed ID: 20302386
[TBL] [Abstract][Full Text] [Related]
23. Rituximab therapy in a patient with autoimmune hemolytic anemia and immune thrombocytopenia associated with chronic lymphocytic leukemia.
Aleem A
Ann Saudi Med; 2008; 28(5):382-5. PubMed ID: 18779631
[No Abstract] [Full Text] [Related]
24. Secondary autoimmune cytopenias in chronic lymphocytic leukemia.
Rogers KA; Woyach JA
Semin Oncol; 2016 Apr; 43(2):300-10. PubMed ID: 27040709
[TBL] [Abstract][Full Text] [Related]
25. Primary and Secondary Immune Cytopenias: Evaluation and Treatment Approach in Children.
Kim TO; Despotovic JM
Hematol Oncol Clin North Am; 2019 Jun; 33(3):489-506. PubMed ID: 31030815
[TBL] [Abstract][Full Text] [Related]
26. Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody).
Karlsson C; Hansson L; Celsing F; Lundin J
Leukemia; 2007 Mar; 21(3):511-4. PubMed ID: 17215854
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults.
Serris A; Amoura Z; Canouï-Poitrine F; Terrier B; Hachulla E; Costedoat-Chalumeau N; Papo T; Lambotte O; Saadoun D; Hié M; Blanche P; Lioger B; Gottenberg JE; Godeau B; Michel M
Am J Hematol; 2018 Mar; 93(3):424-429. PubMed ID: 29247540
[TBL] [Abstract][Full Text] [Related]
28. The prevalence and prognostic significance of autoimmune cytopenias in a cohort of Egyptian patients with chronic lymphocytic leukemia.
Atef B; Azmy E; Aladle D; Mabed M
Hematol Oncol Stem Cell Ther; 2019 Jun; 12(2):97-104. PubMed ID: 30802421
[TBL] [Abstract][Full Text] [Related]
29. Chronic lymphocytic leukemia-associated pure red cell aplasia.
D'Arena G; Cascavilla N
Int J Immunopathol Pharmacol; 2009; 22(2):279-86. PubMed ID: 19505381
[TBL] [Abstract][Full Text] [Related]
30. Cyclosporin A for the treatment of cytopenia associated with chronic lymphocytic leukemia.
Cortes J; O'Brien S; Loscertales J; Kantarjian H; Giles F; Thomas D; Koller C; Keating M
Cancer; 2001 Oct; 92(8):2016-22. PubMed ID: 11596014
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune Lymphoproliferative Syndrome in Children with Nonmalignant Organomegaly, Chronic Immune Cytopenia, and Newly Diagnosed Lymphoma.
Kaya Z; Işık M; Oruklu N; Kirkiz S; Bağrıaçık EÜ; Allende LM; Díaz-Madroñero MJ; Ruiz-García R; Pınarlı FG; Göçün Uyar P; Koçak Ü
Turk J Haematol; 2021 Jun; 38(2):145-150. PubMed ID: 33375216
[TBL] [Abstract][Full Text] [Related]
32. Autoimmune cytopenias in chronic lymphocytic leukemia at disease presentation in the modern treatment era: is stage C always stage C?
Visco C; Cortelezzi A; Moretta F; Falisi E; Maura F; Finotto S; Barcellini W; Ambrosetti A; Neri A; Ruggeri M; Rodeghiero F
Leuk Lymphoma; 2014 Jun; 55(6):1261-5. PubMed ID: 24047107
[TBL] [Abstract][Full Text] [Related]
33. Obinutuzumab in the treatment of autoimmune haemolytic anaemia and immune thrombocytopenia in patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma.
Herishanu Y; Levi S; Kamdjou T; Bornstein Y; Ram R; Benyamini N; Varon D; Avivi I; Perry C
Br J Haematol; 2021 Jan; 192(1):e1-e4. PubMed ID: 33095444
[No Abstract] [Full Text] [Related]
34. Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab--incidence and predictors.
Borthakur G; O'Brien S; Wierda WG; Thomas DA; Cortes JE; Giles FJ; Kantarjian HM; Lerner S; Keating MJ
Br J Haematol; 2007 Mar; 136(6):800-5. PubMed ID: 17341265
[TBL] [Abstract][Full Text] [Related]
35. Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases.
Zaja F; Vianelli N; Sperotto A; Patriarca F; Tani M; Marin L; Tiribelli M; Candoni A; Baccarani M; Fanin R
Leuk Lymphoma; 2003 Nov; 44(11):1951-5. PubMed ID: 14738149
[TBL] [Abstract][Full Text] [Related]
36. Laparoscopic splenectomy for autoimmune hemolytic anemia in patients with chronic lymphocytic leukemia: a case series and review of the literature.
Hill J; Walsh RM; McHam S; Brody F; Kalaycio M
Am J Hematol; 2004 Mar; 75(3):134-8. PubMed ID: 14978692
[TBL] [Abstract][Full Text] [Related]
37. Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study.
Montillo M; O'Brien S; Tedeschi A; Byrd JC; Dearden C; Gill D; Brown JR; Barrientos JC; Mulligan SP; Furman RR; Cymbalista F; Plascencia C; Chang S; Hsu E; James DF; Hillmen P
Blood Cancer J; 2017 Feb; 7(2):e524. PubMed ID: 28157216
[No Abstract] [Full Text] [Related]
38. ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients.
Zanotti R; Frattini F; Ghia P; Visco C; Zamò A; Perbellini O; Stella S; Facco M; Giaretta I; Chilosi M; Pizzolo G; Ambrosetti A
Am J Hematol; 2010 Jul; 85(7):494-8. PubMed ID: 20575031
[TBL] [Abstract][Full Text] [Related]
39. Management of autoimmune cytopenia complicating chronic lymphocytic leukemia.
Zent CS; Shanafelt T
Leuk Lymphoma; 2009 Jun; 50(6):863-4. PubMed ID: 19455465
[No Abstract] [Full Text] [Related]
40. Recurrence of autoimmune thrombocytopenia after treatment with fludarabine in a patient with chronic lymphocytic leukemia.
Montillo M; Tedeschi A; Leoni P
Leuk Lymphoma; 1994 Sep; 15(1-2):187-8. PubMed ID: 7858499
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]